TURKISH JOURNAL OF ONCOLOGY 2022 , Vol 37 , Num 2
Can A Dedicated Multidisciplinary Tumor Board Improve Personalized Medicine for Patients in Interventional Oncology? A Large Retrospective Single-Center Experience
Roberto IEZZI1,Bruno FIONDA2,Patrizia CORNACCHİONE2,Martina IEZZI3,Valentina LANCELLOTTA2,Andrea CONTEGIACOMO1,Fabia ATTILI4,Alberto LARGHI4,Francesco CELLINI2,Fabio MARAZZI2,Giuseppe COLLOCA2,Ángeles ROVIROSA5,György KOVÁCS6,Maria Antonietta GAMBACORTA2,Riccardo MANFREDI1,Vincenzo VALENTINI2,Luca TAGLIAFERRI2
1Department of Diagnostic Imaging, Fondazione Policlinico Universitario ?A. Gemelli? IRCCS, Radiation Oncology and Hematology, U.O.C. of Diagnostic and General Interventional Radiology, Rome-Italy
2Department of Diagnostic Imaging, Fondazione Policlinico Universitario ?A. Gemelli? IRCCS, Radiation Oncology and Hematology, U.O.C. of Radiation Oncology Therapy, Rome-Italy
3Sacred Heart Catholic University, Institute of Radiology, Rome-Italy
4Fondazione Policlinico Universitario ?A. Gemelli? IRCCS, Digestive Endoscopy Unit, Rome-Italy
5Department of Radiation Oncology, Hospital Clinic I Universitari, Barcelona-Spain
6Sacred Heart Catholic University, Educational Program Director Gemelli-INTERACTS, Rome-Italy
DOI : 10.5505/tjo.2022.2819 Keywords :